Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating activities
Net income (loss)	$ 131,066	$ (2,807)
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation, amortization and accretion	15,445	14,615
Impairment of long-lived assets	0	132,052
Amortization of debt related costs	1,073	1,082
Changes in fair value of contingent assets and liabilities	0	(1,400)
Provision for excess and obsolete inventory	2,757	680
Stock-based compensation	15,384	9,667
Gain on disposal of assets	(6,254)	0
Unrealized gain on investment in equity securities	(60,704)	0
Charges incurred in connection with acquired IPR&D	28,000	0
Deferred taxes	11,260	(35,863)
Long-term indemnification receivable	0	(96)
Long-term income tax payable and other long-term liabilities	439	123
Other	1,696	1,225
Changes in assets and liabilities which provided (used) cash:
Accounts receivable	(55,440)	(24,681)
Inventory	(8,494)	(7,124)
Other current assets	4,023	2,479
Accounts payable	(3,462)	6,747
Accrued expenses and other liabilities	50,449	11,801
Net cash provided by operating activities	127,238	108,500
Investing activities
Capital expenditures	(8,273)	(9,168)
Acquisition of assets, net	0	(35,345)
Proceeds from sale of assets	8,000	0
Purchases of investment in equity securities	(78,256)	0
Acquisition of exclusive license option	(28,000)	0
Net cash used in investing activities	(106,529)	(44,513)
Financing activities
Payments on long-term debt and other borrowings	(184)	(297)
Proceeds from stock option exercises	934	1,842
Proceeds from issuance of common stock	1,823	940
Payments for minimum statutory tax withholding related to net share settlement of equity awards	(19,418)	(11,154)
Net cash used in financing activities	(16,845)	(8,669)
Effect of foreign exchange rates on cash, cash equivalents and restricted cash	770	(98)
Net increase in cash, cash equivalents and restricted cash	4,634	55,220
Cash, cash equivalents and restricted cash, beginning of period	715,285	417,241
Cash, cash equivalents and restricted cash, end of period	719,919	472,461
Reconciliation to amounts within the condensed consolidated balance sheets
Cash and cash equivalents	718,279	470,863
Restricted cash included in other long-term assets	1,640	1,598
Cash, cash equivalents and restricted cash at end of period	719,919	472,461
Schedule of non-cash investing and financing activities
Additions of property, plant and equipment included in liabilities	6,853	8,443
Lease liability settled through transfer of lease	$ 376	$ 0